Literature DB >> 19909702

What are the risk factors of occurence and chronicity of neuropathic pain in spinal cord injury patients?

A Margot-Duclot1, H Tournebise, M Ventura, C Fattal.   

Abstract

OBJECTIVE: Analyze the epidemiological data on neuropathic pain in spinal cord injury patients and determine the risk factors for its occurrence and chronicity.
METHOD: Review and analysis of the literature.
RESULTS: Epidemiological data report that 40% of spinal cord injury (SCI) patients suffer from neuropathic pain and 40% of these patients report an intense neuropathic pain. Some factors do not seem to be predictive for the onset of neuropathic pain: the level of injury, complete or incomplete injury, the existence of an initial surgery, sex. However, old age at the time of injury, bullet injury as the cause of trauma, early onset of pain in the weeks following the injury, their initial nature, intensity and continuous pain, as well as associated symptoms all appear to be negative prognostic factors.
CONCLUSION: Neuropathic pain in SCI patients is a major issue, its determining factors still need to be evaluated properly by refining the epidemiological data.

Entities:  

Mesh:

Year:  2009        PMID: 19909702     DOI: 10.1016/j.rehab.2008.12.003

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  10 in total

1.  Increased psychological distress among individuals with spinal cord injury is associated with central neuropathic pain rather than the injury characteristics.

Authors:  Hila Gruener; Gabi Zeilig; Yocheved Laufer; Nava Blumen; Ruth Defrin
Journal:  Spinal Cord       Date:  2017-12-14       Impact factor: 2.772

Review 2.  Effectiveness of transcranial direct current stimulation for the management of neuropathic pain after spinal cord injury: a meta-analysis.

Authors:  S Mehta; A McIntyre; S Guy; R W Teasell; E Loh
Journal:  Spinal Cord       Date:  2015-07-21       Impact factor: 2.772

Review 3.  Non-invasive Brain Stimulation for Central Neuropathic Pain.

Authors:  Qi-Hao Yang; Yong-Hui Zhang; Shu-Hao Du; Yu-Chen Wang; Yu Fang; Xue-Qiang Wang
Journal:  Front Mol Neurosci       Date:  2022-05-19       Impact factor: 6.261

4.  The characteristics of chronic pain after non-traumatic, non-compressive myelopathy: Focus on neuropathic pain.

Authors:  Young In Eom; Min Kim; In Soo Joo
Journal:  J Spinal Cord Med       Date:  2016-08-31       Impact factor: 1.985

5.  Effectiveness of amitriptyline and lamotrigine in traumatic spinal cord injury-induced neuropathic pain: a randomized longitudinal comparative study.

Authors:  N Agarwal; M Joshi
Journal:  Spinal Cord       Date:  2016-08-16       Impact factor: 2.772

6.  A Primary Care Provider's Guide to Pain After Spinal Cord Injury: Screening and Management.

Authors:  Jithin Varghese; Kim D Anderson; Eva Widerström-Noga; Upender Mehan
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

7.  Commentary: Non-invasive Brain Stimulation, a Tool to Revert Maladaptive Plasticity in Neuropathic Pain.

Authors:  Marta Zantedeschi; Mariella Pazzaglia
Journal:  Front Hum Neurosci       Date:  2016-10-27       Impact factor: 3.169

8.  Management of pain in individuals with spinal cord injury: Guideline of the German-Speaking Medical Society for Spinal Cord Injury.

Authors:  Steffen Franz; Barbara Schulz; Haili Wang; Sabine Gottschalk; Florian Grüter; Jochen Friedrich; Jean-Jacques Glaesener; Fritjof Bock; Cordelia Schott; Rachel Müller; Kevin Schultes; Gunther Landmann; Hans Jürgen Gerner; Volker Dietz; Rolf-Detlef Treede; Norbert Weidner
Journal:  Ger Med Sci       Date:  2019-06-17

9.  Go Virtual to Get Real: Virtual Reality as a Resource for Spinal Cord Treatment.

Authors:  Erik Leemhuis; Rita Maria Esposito; Luigi De Gennaro; Mariella Pazzaglia
Journal:  Int J Environ Res Public Health       Date:  2021-02-13       Impact factor: 3.390

Review 10.  Clinical translation of autologous Schwann cell transplantation for the treatment of spinal cord injury.

Authors:  James Guest; Andrea J Santamaria; Francisco D Benavides
Journal:  Curr Opin Organ Transplant       Date:  2013-12       Impact factor: 2.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.